Reliability and Validity of the Combined Heart Rate and Movement Sensor Actiheart
Overview
Authors
Affiliations
Unlabelled: Accurate quantification of physical activity energy expenditure is a key part of the effort to understand disorders of energy metabolism. The Actiheart, a combined heart rate (HR) and movement sensor, is designed to assess physical activity in populations.
Objective: To examine aspects of Actiheart reliability and validity in mechanical settings and during walking and running.
Methods: In eight Actiheart units, technical reliability (coefficients of variation, CV) and validity for movement were assessed with sinusoid accelerations (0.1-20 m/s(2)) and for HR by simulated R-wave impulses (25-250 bpm). Agreement between Actiheart and ECG was determined during rest and treadmill locomotion (3.2-12.1 km/h). Walking and running intensity (in J/min/kg) was assessed with indirect calorimetry in 11 men and nine women (26-50 y, 20-29 kg/m(2)) and modelled from movement, HR, and movement + HR by multiple linear regression, adjusting for sex.
Results: Median intrainstrument CV was 0.5 and 0.03% for movement and HR, respectively. Corresponding interinstrument CV values were 5.7 and 0.03% with some evidence of heteroscedasticity for movement. The linear relationship between movement and acceleration was strong (R(2) = 0.99, P < 0.001). Simulated R-waves were detected within 1 bpm from 30 to 250 bpm. The 95% limits of agreement between Actiheart and ECG were -4.2 to 4.3 bpm. Correlations with intensity were generally high (R(2) > 0.84, P < 0.001) but significantly highest when combining HR and movement (SEE < 1 MET).
Conclusions: The Actiheart is technically reliable and valid. Walking and running intensity may be estimated accurately but further studies are needed to assess validity in other activities and during free-living.
Sponsorship: The study received financial support from the Wellcome Trust and SB was supported by a scholarship from Unilever, UK.
Taylor M, Bradford M, Zhou C, Fladeboe K, Wittig J, Baker K Cancer Med. 2025; 14(4):e70609.
PMID: 39981705 PMC: 11843223. DOI: 10.1002/cam4.70609.
Kraav J, Zagura M, Viitasalo A, Soininen S, Veijalainen A, Kahonen M J Am Heart Assoc. 2024; 13(22):e035790.
PMID: 39508145 PMC: 11681410. DOI: 10.1161/JAHA.124.035790.
Raw Photoplethysmography as an Enhancement for Research-Grade Wearable Activity Monitors.
Hibbing P, Khan M JMIR Mhealth Uhealth. 2024; 12:e57158.
PMID: 39331461 PMC: 11470225. DOI: 10.2196/57158.
Mapping biological influences on the human plasma proteome beyond the genome.
Carrasco-Zanini J, Wheeler E, Uluvar B, Kerrison N, Koprulu M, Wareham N Nat Metab. 2024; 6(10):2010-2023.
PMID: 39327534 PMC: 11496106. DOI: 10.1038/s42255-024-01133-5.
Rieckmann A, Jordan B, Burczik F, Meixner J, Thiel C PLoS One. 2024; 19(8):e0309481.
PMID: 39190715 PMC: 11349177. DOI: 10.1371/journal.pone.0309481.